Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 1457-1471
Publisher
Informa UK Limited
Online
2022-05-16
DOI
10.2147/dddt.s356988
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clocks, cancer, and chronochemotherapy
- (2021) Aziz Sancar et al. SCIENCE
- Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations
- (2021) Wagdy M. Eldehna et al. BIOORGANIC CHEMISTRY
- Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies
- (2021) Nancy Y. Guerrero-Pepinosa et al. BIOMEDICINE & PHARMACOTHERAPY
- Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer
- (2021) Peter A. Halim et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Dual Kinase Inhibition of EGFR/HER2: Design, Synthesis and Molecular Docking of Thiazolylpyrazolyl‐Based Aminoquinoline Derivatives as Anticancer Agents**
- (2021) Rasha Z. Batran et al. ChemistrySelect
- Targeted Therapies in Cancer: To Be or Not to Be, Selective
- (2021) Skye Montoya et al. Biomedicines
- Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents
- (2020) Heba Abdelrasheed Allam et al. BIOORGANIC CHEMISTRY
- Design, Synthesis, Molecular Docking and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide tail as EGFR Kinase Inhibitors
- (2020) Farah Nawaz et al. Anti-Cancer Agents in Medicinal Chemistry
- A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
- (2020) Adileh Ayati et al. BIOORGANIC CHEMISTRY
- Some 1,3,5-trisubstituted pyrazoline derivatives targeting breast cancer: Design, synthesis, cytotoxic activity, EGFR inhibition and molecular docking
- (2020) Riham F. George et al. BIOORGANIC CHEMISTRY
- Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview
- (2020) Dimitris Matiadis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies
- (2020) Wagdy M. Eldehna et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis
- (2019) Mai Maher et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis
- (2019) Tahia K. Mohamed et al. BIOORGANIC CHEMISTRY
- Thiazole in the targeted anticancer drug discovery
- (2019) Adileh Ayati et al. Future Medicinal Chemistry
- Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors
- (2019) Esraa A. Abdelsalam et al. BIOORGANIC CHEMISTRY
- Recent advances of thiazole hybrids in biological applications
- (2019) Mehmet Gümüş et al. Future Medicinal Chemistry
- Synthesis of some novel pyrazoline‐thiazole hybrids and their antimicrobial activities
- (2019) Doaa M. Masoud et al. JOURNAL OF HETEROCYCLIC CHEMISTRY
- Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors
- (2019) Belgin Sever et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Thiazole-containing compounds as therapeutic targets for cancer therapy
- (2019) Prabodh Chander Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Comprehensive Review on Recent Developments in the Field of Biological Applications of Potent Pyrazolines Derived from Chalcone Precursors
- (2018) Vinutha V. Salian et al. Letters in Drug Design & Discovery
- Anticancer Potential of Thiazole Derivatives: A Retrospective Review
- (2018) Shweta Jain et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway
- (2018) Ping Zhou et al. Oncology Letters
- A Review on Recent Synthetic Strategies and Pharmacological Importance of 1,3-Thiazole Derivatives
- (2018) Swarna Gowri et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors
- (2018) Riham F. George et al. BIOORGANIC CHEMISTRY
- Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis
- (2017) Mostafa MM El-Miligy et al. Future Medicinal Chemistry
- Unveiling a versatile heterocycle: pyrazoline – a review
- (2017) Beena Varghese et al. RSC Advances
- Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline–thiazolidine-based hybrids
- (2016) Dmytro Havrylyuk et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Current developments of coumarin-based anti-cancer agents in medicinal chemistry
- (2015) Saeed Emami et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents
- (2014) Ji-Wen Yuan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, molecular modeling and biological evaluation of cinnamic acid derivatives with pyrazole moieties as novel anticancer agents
- (2014) Wei-Ming Zhang et al. RSC Advances
- Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors
- (2012) Ke-Ming Qiu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Recent advances in the therapeutic applications of pyrazolines
- (2012) Mohamed R Shaaban et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Gefitinib Inhibits the Proliferation of Pancreatic Cancer Cells via Cell Cycle Arrest
- (2009) Xiaohua Zhou et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy
- (2009) Isamu Okamoto FEBS Journal
- Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure−Activity Relationships
- (2009) Yan Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started